Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin

    • Product Name 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin
    • Alias Bromadiolone
    • Einecs 826-719-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    619144

    Iupac Name 3-[3-(4-Bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one
    Molecular Formula C32H23BrO3
    Molecular Weight 535.43 g/mol
    Cas Number 144389-92-0
    Appearance White to off-white powder
    Melting Point 179-183°C
    Solubility Slightly soluble in DMSO, ethanol
    Structure Type Coumarin derivative
    Pubchem Cid 6918402
    Functional Groups Hydroxy, brominated biphenyl, coumarin
    Chemical Class Anticoagulant (warfarin-like)
    Boiling Point Decomposes before boiling
    Smiles C1=CC=C(C=C1)C(C(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)(C4=CC=CC=C4)O)C5=CC6=C(C=C5)OC(=O)C=C6O

    As an accredited 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 5 grams of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin, labeled with chemical details and safety information.
    Shipping The chemical `3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin` is shipped in sealed, inert containers to prevent contamination and degradation. Packaging complies with regulatory standards, including labeling for hazardous materials, and is cushioned to prevent physical damage during transit. Temperature control may be provided if stability data requires it.
    Storage Store **3-[3-(4-Bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin** in a tightly sealed container, protected from light and moisture. Keep at 2–8°C in a refrigerator or a cool, dry environment. Avoid exposure to heat or sources of ignition. Label appropriately and handle under a fume hood if powder/dust exposure is possible. Keep away from incompatible substances and store following standard chemical safety protocols.
    Application of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin

    Applications of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin in Industrial Manufacturing

    Our production of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin supplies advanced intermediate functions to critical downstream industries. As a chemical raw material manufacturer, we provide this compound in high batch consistency, supporting well-established and regulated application routes where specialized coumarin derivatives play a central role in finished goods formulation, synthesis processes, and end-use performance. Below, we outline specific industrial applications with detailed compliance protocols, recommended formulation ratios, integration steps, and target end products.

    1. Anticoagulant Pharmaceutical Intermediate Synthesis

    This compound serves as a core intermediate in the synthesis of selective oral anticoagulant active substances, especially for the manufacture of novel vitamin K antagonists (VKAs). Its unique structure supports complex coupling reactions, contributing to high-yield, high-purity synthesis of drug actives under stringent regulatory controls. Our material supports process reliability for pharmaceutical-grade APIs produced in cGMP environments requiring fully traceable, specification-controlled input chemicals.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for APIs
    • Chinese Pharmacopoeia (ChP)
    • USP <797>, <823> concerning active intermediates
    • EU EudraLex Volume 4, Part I (Annex 3: Manufacture of Intermediate Products)

    Typical usage ratio

    • Applied at 1-7% w/w in multi-step synthesis; adjusted based on molar equivalents for target API yield

    Downstream process integration

    • Introduced during initial condensation and coupling stages
    • Batch added to reactor pre-neutralization and purification phase
    • Monitored for input purity and conversion rate before isolation of pharmaceutical intermediate

    Final product types

    • Oral anticoagulant API (e.g., coumarin-type VKAs)
    • Finished solid dosage forms (tablets/capsules)
    • Bulk powder APIs for B2B licensed supply

    2. Specialty Dyes and Fluorescent Probe Manufacturing

    This compound acts as a specialized intermediate in the synthesis of high-performance organic dyes and fluorescent labeling reagents. Its extended aromatic system and bromine substitution make it a preferred precursor for producing application-specific conjugated dye molecules. Major dye manufacturers utilize the material for batchwise synthesis of products for bioimaging or optoelectronic device integration, where high quantum yield and target emission wavelengths are paramount.

    Industry compliance standards

    • REACH Regulation (EC No 1907/2006)
    • EN 71-5: Safety of toys - Chemical toys (chemical experiment sets) including dyestuff limits
    • ISO 9001 certified dye production procedure

    Typical usage ratio

    • Usually employed at 0.5-2.5% w/w depending on fluorophore design and emission requirements

    Downstream process integration

    • Fed directly into coupling and cyclization reactors as the key aromatic precursor
    • Controls the color yield, photostability, and functional moiety integration in the dye structure
    • Required to meet spectral performance specifications post-synthesis

    Final product types

    • Fluorescent dyes for microscopy, cell labeling kits
    • Reactive probes for immunoassay reagent kits
    • OLED and optoelectronic material intermediates

    3. Fine Chemical Reference Standard and Analytical Reagent Production

    Regulated laboratories use this compound as a reference material in fine chemical and pharmaceutical research as well as quality control (QC) systems. With rigorous batch-specific analytical documentation, it contributes to reliable chromatographic, spectrometric and bioassay calibrations. Major reference standard producers select this raw material for further purification and certification to supply fully characterized analytical standards required in method validation, impurity profiling, and system suitability testing.

    Industry compliance standards

    • ISO 17034: General requirements for the competence of reference material producers
    • FDA 21 CFR part 211, Subpart I – Laboratory controls
    • USP General Chapter <1226> Verification of Compendial Procedures

    Typical usage ratio

    • Purity of >98% required; input amount set according to milligram to gram scale for final reference standard output

    Downstream process integration

    • Used in recrystallization and chromatographic purification setups for reference material manufacture
    • Integrated at QC laboratory sample preparation, calibration, and validation phases

    Final product types

    • Chemical reference standards for analytical method validation
    • Certified analytical reagents for high-precision testing
    • Laboratory-grade calibration solutions

    4. Research-Grade API Intermediate for Custom Synthesis Services

    Chemical research organizations and CDMOs (Contract Development and Manufacturing Organizations) utilize this compound as a modular synthon in pilot-scale and custom synthesis projects, especially for structurally diverse coumarin-based drug candidates. Its molecular configuration enables a broad range of functional modifications and analog synthesis, supporting structure-activity relationship (SAR) exploration and early-stage drug discovery.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • US FDA Guidance for Industry: Q11 Development and Manufacture of Drug Substances
    • ISO/IEC 17025: Testing and calibration laboratory certification

    Typical usage ratio

    • Applied at 1-10% w/w as a lead structure in custom routes; usage based on target product molarity and modification protocol

    Downstream process integration

    • Integrated into reaction sequences for stepwise synthesis and analog building
    • Used in route optimization trials for improved yield and selective product formation
    • Entered at validation/scale-up phase for pilot batch supply

    Final product types

    • Pilot-scale pharmaceutical intermediates
    • NCE (New Chemical Entity) libraries for pharma R&D
    • Experimental drug candidate compounds
    Free Quote

    Competitive 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin: A Chemical Manufacturer's Perspective

    Getting to Know the Product

    In our years running reactors, working side by side with chemists and operators, we come across a range of complex molecules, but few carry the distinct profile of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin. This compound stands apart with its intricate biphenyl core and well-placed hydroxy and bromine functionalities. Our team spends countless hours optimizing parameters—not just for purity, but to achieve consistency in crystallization and particle size at scale. All this work brings forward a product with certain physical characteristics, best handled by professionals who appreciate both its chemical richness and the production hurdles involved.

    The Model and Its Characteristics

    Years back, our R&D team came together with synthetic chemists to fine-tune the batch and continuous flow syntheses of this particular molecule. We focused on reaction conditions gently enough for the fragile hydroxycoumarin segment, while also ensuring full halogen substitution on the biphenyl ring. The resulting material often forms as a pale solid, with good solubility in polar aprotic solvents—the kind most laboratories and industrial processors stock as standard. Spectroscopic data always matter in our process: NMR, HPLC, and IR checks give us confidence that impurities get chipped down well below reporting thresholds. That commitment to reproducibility comes through in the batch-to-batch uniformity users have come to expect from us.

    Most of our production cycles run between the kilogram and multicentric tonne scale, reflecting the real demand from end users worldwide. It's not just about making a name for ourselves with a flashy product; it comes down to listening to custom requests, working with unique purity cutoffs, and scaling campaigns that don’t leave customers high and dry when their own production intensifies or timelines tighten.

    Importance in Industry: Applications and Relevance

    Synthesizing this coumarin derivative usually builds interest from niche pharmaceutical research programs, especially those probing anticoagulant prototypes or selectivity against complex biological targets. Years of dialogue with medicinal chemists point to a growing respect for nuanced molecules like this—where both aromatic rigidity and functional group placement give rise to new molecular mechanisms or ADME properties. We see the compound pop up in SAR studies and as a platform for further derivatization, giving researchers a scaffold that doesn't start them from zero.

    The role of the bromobiphenyl fragment comes through especially strong in late-stage diversification strategies. Sometimes a medicinal chemist picks this building block for cross-coupling reactions, hoping to append new moieties right where the chemistry is most receptive. The hydroxy groups on both the coumarin and propyl arms don’t just sit idle either; they turn this scaffold into a potential ligand or bioisostere, able to slip into places where more rigid or nonpolar structures fail. From my years overseeing kilo-scale campaigns, I've seen how much creative value this gives to downstream teams, whether they're in hit expansion, lead optimization, or enzyme inhibitor trials.

    Production: Lessons Learned and Factory Realities

    Nothing teaches respect for a molecule like having to make hundreds of kilograms of it every year. We learned fast that coumarin chemistry runs into trouble with byproduct formation and subtle pH drifts in big vats. Bromination steps, which sound straightforward in the literature, challenge us with issues like incomplete halogenation or competitive side reactions. We invested heavily in online analytics, catching deviations before they grow into batch-scale headaches. Our biggest improvements grew out of ongoing collaborations with clients, whose feedback drove real process tweaks—sometimes even pushing us to add nights or split the schedule to deliver when projects ran behind.

    Solvent recovery, a major cost driver for operations, took center stage as we ramped up. Moving away from generic chlorinated solvents into more eco-friendly choices not only cut our environmental bill, but also minimized the residuals in the final product. As manufacturers, nobody wants to ship lots with residual traces, not just for compliance, but because we know how dedicated users approach analytical characterization. This mindset shows up in our continued investments in filtration systems, cleanroom-level handling, and demanding purity audits with every campaign.

    Comparison to Other Commercially Available Coumarin Derivatives

    3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin stands in sharp contrast to the more basic hydroxycoumarins and simple biphenyl derivatives available in the open market. The additional bromine and extended biphenyl structure offer unique reactivity not usually found in simpler building blocks. Over the years, we've noticed customers switching from shorter-chain analogs or mono-substituted versions when they needed more reliable downstream transformation or higher selectivity in biochemical assays.

    We track feedback closely—some chemists struggled to achieve selective modifications on less sterically protected coumarins, or found instability issues arising during scale-up with small-molecule coumarins without the biphenyl anchor. Our product, on the other hand, holds up better under oxidative and reductive conditions, and the brominated aromatic system offers more handles for site-selective chemistry. These differences go beyond what shows up on a standard spec sheet; only ongoing production and open dialogue with synthetic scientists can draw out these operational truths.

    Why Purity, Traceability, and Supply Reliability Matter

    From one manufacturer to another, we know you can't afford surprises: untraceable minor components, batch-to-batch drift, or delivery delays throw timelines off and jeopardize project milestones. Every lot of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin passes through rigorous analytics—HPLC UV, LC-MS, and NMR—mirroring what scientists perform in their own labs. We stay transparent with all characterization data, whether the lot hits 99.5% or 98.8%, so you can plan experiments or upgrades without guesswork. Given the scrutiny placed on complex pathways like those used in pharmaceutical development, manufacturers can never rest on assumptions or vague purity statements.

    Supply reliability comes down to more than having a big drum ready to ship. We track raw material sources back to initial lots, monitoring every bottleneck and shortage risk. It isn’t just good business sense—regulatory systems expect this, and users appreciate not fighting with scale-up surprise moments because of a batch shift upstream. This recordkeeping also allows us to serve R&D clients who need regulatory support or clear provenance for filing purposes.

    Environmental Responsibility and Sustainable Manufacturing Practices

    No chemical plant can ignore the tight mesh of regulations and public expectations surrounding sustainability. In manufacturing each batch of 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin, we take nothing for granted. Bromination brings waste challenges; rather than treating this as a cost, we view it as a platform for better practices. We've cut down on heavy-metal use during purification and invested in solvent savings that go straight back into the plant instead of becoming landfill or effluent. This product's scale justifies the shift, and customer feedback supports these investments. Chemists at both ends of the supply chain don't want their innovation to be chained to outdated, unsustainable models.

    Feedback loops with university researchers and environmentally conscious firms led us to adopt more closed-loop setups, and to continuously audit emissions. There’s no easy path, but the competitive market means the customers with the most forward-looking R&D plans choose manufacturers who push for measurable improvement in solvent use, energy management, and waste minimization.

    End-User Experiences: Stories from the Field

    After shipping this compound worldwide, we get stories—good, bad, urgent, and, sometimes, just plain odd. More than once, a user flagged small solubility quirks in their solvent mix, or subtle variations in packdown density, sparking process adjustments at our end. Scale-up teams in pharma often call for repeat batches under expedited timelines, and these partnerships—sometimes spanning years—drive us to maintain stocks, anticipate seasonal raw material swings, and keep dialogue channels wide open. These aren’t just customer service points; they reflect how deep the relationship between manufacturer and end user runs when molecules as versatile as this are in play.

    We also hear about successful integration into automated synthesis platforms and pilot plant production lines, where material reliability underpins everything. By adapting granularity, packaging, and even timeline windows, we turn feedback into action—helping labs stay productive through mergers, moves, or sudden project priority shifts. What matters is responding with speed and openness. Scientists and engineers who trust material will perform the same way every time get to focus on developing the breakthroughs that drive their industries forward.

    Challenges and Solutions

    Manufacturing complex aromatic molecules at scale means hitting problems not outlined in textbooks. Bromine’s reactivity often pushes us to rethink storage and temperature control, especially as ambient swings bring on unexpected crystallizations or degradation. In our plant, we saw product batches occasionally show minor discoloration—nothing hazardous, but enough to delay shipments as QCs re-ran. From these setbacks, we adjusted container handling and staged shipments to remain within ideal temperature ranges. Looking at the supply side, shifting global sources for starting materials forced us to find near-source alternatives and build redundancy into procurement, making sure downstream commitments held even as external events threatened logistics.

    Every issue pushes us to fine-tune, whether it’s adopting new filtration media for extended shelf life or scheduling production campaigns with weather patterns squarely in mind. Customers depend on shipment reliability as much as on chemical quality, so our logistics team works ahead. Through bulk storage at temperature-controlled facilities or rapid-response small-batch synthesis, we've built in adaptability, keeping projects running regardless of market fluctuations or unexpected plant issues.

    Looking Forward: Future Development and Collaboration

    Molecules like 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin won’t disappear from industrial and research pipelines any time soon. As the pharmaceutical landscape evolves, as new therapeutic questions emerge, and as synthetic routes trend toward more sustainable and selective transformations, demand for advanced, well-characterized intermediates remains steady. Our role as a manufacturer continues to shift, driven by end-user requests for tighter specs, greener manufacturing, and faster turnaround. The collaborative process—shared between lab chemists, supply chain managers, and process engineers—drives the whole industry ahead.

    We regularly host site visits and technical workshops for customers interested in scaling or adapting new derivatives. Sharing data, co-developing purification approaches, or even tailoring packing options goes far beyond the old vendor-buyer template. True partnership, built on technical exchange and problem-solving, gets everyone closer to better results in real-world conditions.

    Conclusion: The Value of Depth in Chemical Manufacturing

    Producing and supplying specialty molecules such as 3-[3-(4-Bromobiphenyl-4-Yl)-3-Hydroxy-1-Phenylpropyl]-4-Hydroxycoumarin never comes down to a single run or spec sheet. Behind each batch stands a history of process adjustment, customer dialogue, and continuous technical evolution. The molecule’s combination of structure, functional group richness, and adaptability keeps it firmly demanded across research and commercial sectors.

    Our journey with this compound underscores a lesson familiar to every serious chemical manufacturer: sustainable quality, honest communication, and the constant pursuit of operational improvement set the best suppliers apart. Customers returning for consistent supply year after year prove that commitment matters just as much in the plant as in the lab. That’s a standard we uphold, one batch at a time.